Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

KEYTRUDA 25 mg/mL concentrate for solution for infusion.

Active Ingredient:
pembrolizumab
About Medicine
{medical_services}
Prescription only medicine
Patient Leaflet (PIL) Product Information HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 23 May 2025
{pdf} View or print the patient leaflet as PDF
Merck Sharp & Dohme (UK) Limited
Company image
Address
120 Moorgate, London, EC2M 6UR, UK
WWW
http://www.msd-uk.com/
Telephone
+44 (0)208 154 8000 (all hours)
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)208 154 8001